Andrew L Chan

US Patent:

57926387, Aug 11, 1998

Filed:

May 24, 1994

Appl. No.:

8/247946

Inventors:

Stuart A. Aaronson - New York NY
Andrew Chan - New York NY
Toru Miki - Rockville MD

Assignee:

The United States of America as represented by the Department of Health
and Human Services - Rockville MD

International Classification:

C12N 916
C12N 1501
C12N 1512
C12Q 168

US Classification:

435194

Abstract:

The oncogene of the present invention, isolated by expression cloning from a human ovarian cancer is a mutant of TC21. The present invention teaches that ras-related genes not thought to have transforming potential can contribute importantly to cancers which have been refractory to oncogene detection. The present invention teaches that another ras relative gene, R-ras, which was previously reported to lack transforming potential, has transforming capacity as well. Thus, these and other genes similarly related to prototype and activated by analogous mechanisms may be important in the diagnosis and prognosis of certain cancers, as well as be critical in the design of rational approaches to therapy of cancers in which they play a role.

US Patent:

20200388379, Dec 10, 2020

Filed:

Jun 5, 2020

Appl. No.:

16/894632

Inventors:

- Los Angeles CA, US
Andrew Chan - Los Angeles CA, US
Kevin Beyer - Los Angeles CA, US
Amanda Steenbergen - Indianapolis IN, US
Brian Schilb - Indianapolis IN, US
Grant Murakami - Honolulu HI, US
Juan Yu - Los Angeles CA, US
Eric Zudak - Indianapolis IN, US
Craig Otta - Davenport IA, US
Gabe Kwok - Los Angeles CA, US
Daria Coltrain - Los Angeles CA, US
Michael Demo - Indianapolis IN, US

International Classification:

G16H 40/20
G09B 5/06
G06Q 50/20
G06Q 10/10
G16H 10/20
G06Q 10/06
G16H 70/20
H04N 21/2187

Abstract:

A method for reducing training requirements for clinical trial staff including receiving clinical trial information for a clinical trial, wherein the clinical trial information includes one or more clinical trial tasks, one or more training units associated with at least one of the tasks, and clinical trial protocol requirements; providing a list of the clinical trial tasks to a user for selection, wherein the user is a member of the clinical trial staff; generating a training program for the user, comprising a plurality of assigned training units, wherein each of the assigned training units are associated with the selected clinical trial tasks; providing the assigned training units from the training program to the user for completion; documenting completion of the assigned training units; and documenting confirmation that the user is qualified for the clinical trial after completion of the assigned training units, wherein confirmation is provided by a principal investigator.

US Patent:

20170305552, Oct 26, 2017

Filed:

Dec 2, 2015

Appl. No.:

15/518103

Inventors:

- Carson CA, US
Andrew CHAN - Alhambra CA, US
Sung HONG - Los Angeles CA, US

Assignee:

MAG Aerospace Industries, LLC - Carson CA

International Classification:

B64D 11/02
E03F 1/00
E03C 1/12
A47J 31/44
B60R 15/04

Abstract:

Embodiments of the present disclosure relate generally to a reservoir () that is easily removed from a grey water flush system. The reservoir is made modular so that rather than removing an entire reservoir/pump/circuitry system, the reservoir () can be separately removed from the system. The reservoir can also be made disposable, which can save cleaning and refurbishment costs. This can also increase turn-around time for maintenance of the system.